AbbVie (ABBV) shares dropped 4% in midday trading on Friday after the pharmaceutical company reported higher operating expenses, as expected, and posted earnings and revenue that beat Wall Street's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback